Ligand validation:9I6H

LFA: EICOSANE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9I6H_LFA_C_309	61%	69%	0.136	0.926	0.29	0.88	-	-	0	0	100%	1
9I6H_LFA_D_311	58%	69%	0.13	0.935	0.29	0.88	-	-	0	0	85%	1
9I6H_LFA_D_309	47%	69%	0.163	0.902	0.28	0.91	-	-	0	0	100%	1
9I6H_LFA_D_310	37%	68%	0.183	0.882	0.29	0.92	-	-	0	0	100%	1
9I6H_LFA_E_311	31%	73%	0.147	0.923	0.31	0.73	-	-	0	0	40%	1
9I6H_LFA_E_312	27%	71%	0.184	0.886	0.3	0.82	-	-	1	0	70%	1
9I6H_LFA_E_315	27%	75%	0.163	0.926	0.31	0.67	-	-	0	0	35%	1
9I6H_LFA_A_314	25%	73%	0.15	0.894	0.31	0.73	-	-	0	0	40%	1
9I6H_LFA_B_308	22%	73%	0.191	0.912	0.31	0.72	-	-	0	0	40%	1
9I6H_LFA_D_313	21%	77%	0.181	0.919	0.31	0.59	-	-	0	0	30%	1
9I6H_LFA_C_310	20%	79%	0.167	0.907	0.32	0.55	-	-	0	0	25%	1
9I6H_LFA_C_313	20%	78%	0.169	0.894	0.31	0.57	-	-	0	0	30%	1
9I6H_LFA_B_309	19%	71%	0.199	0.882	0.31	0.78	-	-	0	0	50%	1
9I6H_LFA_C_308	19%	73%	0.203	0.902	0.31	0.72	-	-	0	0	40%	1
9I6H_LFA_A_317	18%	78%	0.195	0.906	0.31	0.57	-	-	0	0	30%	1
9I6H_LFA_B_313	17%	72%	0.19	0.847	0.3	0.77	-	-	0	0	55%	1
9I6H_LFA_A_320	16%	72%	0.193	0.863	0.29	0.78	-	-	0	0	45%	1
9I6H_LFA_E_313	16%	70%	0.203	0.918	0.41	0.73	-	-	0	0	20%	1
9I6H_LFA_D_314	16%	75%	0.186	0.873	0.31	0.65	-	-	0	0	35%	1
9I6H_LFA_E_314	16%	79%	0.203	0.906	0.32	0.55	-	-	0	0	25%	1
9I6H_LFA_A_318	14%	69%	0.22	0.808	0.3	0.87	-	-	0	0	80%	1
9I6H_LFA_B_310	13%	75%	0.21	0.872	0.3	0.68	-	-	0	0	35%	1
9I6H_LFA_E_303	13%	71%	0.259	0.889	0.3	0.8	-	-	0	0	50%	1
9I6H_LFA_D_312	12%	74%	0.219	0.871	0.31	0.68	-	-	1	0	35%	1
9I6H_LFA_C_311	11%	70%	0.211	0.874	0.41	0.74	-	-	0	0	20%	1
9I6H_LFA_B_314	11%	71%	0.227	0.822	0.3	0.81	-	-	0	0	55%	1
9I6H_LFA_E_317	10%	73%	0.221	0.809	0.31	0.74	-	-	0	0	50%	1
9I6H_LFA_A_313	9%	75%	0.239	0.852	0.31	0.65	-	-	0	0	35%	1
9I6H_LFA_B_307	8%	73%	0.228	0.791	0.31	0.73	-	-	2	0	45%	1
9I6H_LFA_A_315	5%	73%	0.284	0.812	0.31	0.71	-	-	0	0	40%	1
9I6H_LFA_C_314	4%	79%	0.274	0.784	0.32	0.55	-	-	0	0	25%	1
9I6H_LFA_A_316	2%	70%	0.273	0.705	0.41	0.74	-	-	0	0	20%	1
9I6H_LFA_E_316	1%	78%	0.341	0.586	0.31	0.57	-	-	1	0	30%	1
9I6I_LFA_D_313	67%	69%	0.117	0.953	0.3	0.86	-	-	0	0	85%	1
6RF6_LFA_A_307	50%	79%	0.101	0.904	0.23	0.62	-	-	0	0	70%	1
4XTL_LFA_A_315	46%	89%	0.079	0.949	0.26	0.38	-	-	1	0	25%	1
4XTN_LFA_J_311	43%	74%	0.092	0.958	0.38	0.61	-	-	1	0	20%	1
6XYT_LFA_C_309	41%	100%	0.165	0.878	0.07	0.05	-	-	0	0	100%	1
6SU4_LFA_X_616	66%	100%	0.113	0.917	0.09	0.1	-	-	0	0	100%	1
6SU3_LFA_X_301	65%	96%	0.071	0.945	0.18	0.18	-	-	0	0	60%	1
7AKY_LFA_A_403	58%	99%	0.088	0.911	0.08	0.14	-	-	7	0	75%	1
8QLF_LFA_A_408	56%	100%	0.083	0.933	0.1	0.06	-	-	1	0	55%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.